How can ophthalmologists better educate patients about the severity of DME progression?
Comparison of brolucizumab and aflibercept for treating DME
Curacle presents results of phase 2a clinical trial of CU06 for diabetic macular edema
European Medicines Agency approves faricimab (Vabysmo) 6.0 mg single-dose prefilled syringe
Serum inflammation biomarkers level in cystoid and diffuse diabetic macular edema
DelveInsight releases report of in-depth background and trends of the diabetic macular edema
Flagship dataset released to better understand type 2 diabetes development